Why did the price of INJ go up?

Injective (INJ) increased by 3.75% in the last 24 hours, outperforming the overall crypto market’s 2.18% gain. This move fits within a larger 8.61% upward trend over the past week. Here are the main reasons behind this growth:

1. Launch of Pre-IPO Perpetuals (Positive) – New onchain derivatives for private companies like OpenAI have started trading, boosting platform activity.
2. Growth in Institutional Treasury (Positive) – Pineapple Financial’s $100 million fund focused on INJ shows strong interest from institutional investors.
3. Technical Breakout (Mixed) – The price has moved above important Fibonacci levels but faces resistance near $13.50.

Deep Dive

1. Launch of Pre-IPO Derivatives (Positive Impact)

Overview:
On October 1, Injective introduced decentralized perpetual markets for pre-IPO companies such as OpenAI. These markets offer 5x leverage and are available 24/7 through the Helix platform. This expands Injective’s decentralized finance (DeFi) offerings beyond just cryptocurrencies (The Block).

What this means:

• Attracts traders interested in private companies with high growth potential.
• Increases fees collected by the platform, which supports Injective’s deflationary mechanism where 60% of fees are permanently removed from circulation.
• Sets Injective apart from competitors like Robinhood, which also offers tokenized equity products but in a different way.

What to watch:
Look for announcements about more pre-IPO companies being added in October and updates on trading volume from Helix.

2. Institutional Treasury Expansion (Positive Impact)

Overview:
Pineapple Financial (NYSE: PAPL) raised $100 million to create a treasury focused on Injective, aiming to generate about 12% returns through staking. This follows Injective’s efforts in September to attract institutional investors (CCN).

What this means:

• Reduces the number of INJ tokens available on the market, as Pineapple plans to hold roughly 7% of the total supply.
• Shows that traditional investors see INJ as a valuable asset that can generate steady income.
• Follows a strategy similar to other blockchains like Solana and Avalanche, which have used staking to increase token demand.

3. Technical Momentum (Mixed Impact)

Overview:
INJ’s price has moved above its 7-day simple moving average (SMA) of $12.62 and is testing the 38.2% Fibonacci retracement level at $13.47. The MACD indicator has turned positive (+0.075), suggesting short-term upward momentum.

What this means:

• If the price closes above $13.50, it could aim for the next target around $14.00 (the 50% Fibonacci level).
• If the price falls below $12.76, some traders might take profits, causing a pullback.
• The Relative Strength Index (RSI) at 50.78 indicates there is still room for the price to rise before it becomes overbought.

Conclusion

Injective’s recent price increase is supported by strong factors: the launch of innovative pre-IPO derivatives, growing institutional interest through treasury expansion, and positive technical signals. The $13.50 level is a key resistance point. If INJ can stay above this price with increasing trading volume, it may continue to rise. Otherwise, some profit-taking could slow the momentum.

Key question: Will INJ maintain its position above $13.50 with growing demand, or will traders cash out and reverse the breakout?

What could affect the price of INJ?

Injective’s price depends on upcoming protocol upgrades, growth in real-world asset (RWA) trading, and changes in regulations.

1. Ecosystem Growth – New AI tools and pre-IPO derivatives attract developers and traders
2. Tokenomics Changes – Token burns reduce supply, plus a $100 million corporate treasury buy-in
3. Regulatory Risks – SEC delays approval of a staked ETF, increasing scrutiny on altcoins

Deep Dive

1. Protocol Upgrades & Adoption (Positive Outlook)

Overview:
In Q3 2025, Injective plans to launch iBuild, an AI-powered app builder, and Ethernia EVM, which makes it easier for Ethereum developers to build on Injective. These upgrades lower the technical barriers for developers. Recently, pre-IPO perpetual markets for companies like OpenAI and SpaceX generated over $1 billion in RWA derivatives trading volume (Helix Markets).

What this means:

• Easier app development could boost activity on the Injective platform, increasing demand for INJ tokens used for transaction fees and staking.
• Trading of real-world asset derivatives now makes up 17% of the protocol’s revenue, which supports the token burn process, reducing the total supply of INJ.

2. Corporate & Institutional Demand (Mixed Impact)

Overview:
Pineapple Financial has invested $100 million in INJ tokens, representing about 7% of the circulating supply, aiming for 12% staking returns. Meanwhile, Canary Capital’s staked ETF application is delayed by the SEC (Cointelegraph).

What this means:

• Pineapple’s large token purchase reduces the number of tokens available for sale, supporting the price.
• However, delays in ETF approval could limit new institutional investments in the short term, despite filings by exchanges like CBOE.

3. Market Sentiment & Liquidity (Potential Risks)

Overview:
INJ’s price movement remains closely linked to Bitcoin, with a 90-day correlation of 0.82. The crypto Fear & Greed Index stands at 59, indicating a neutral but cautious market ahead of U.S. election-related policy changes.

What this means:

• A broad market downturn could cause INJ’s price to drop significantly (it’s down 35% year-over-year, compared to Bitcoin’s 12% decline).
• Moderate liquidity means that large sell orders could cause bigger price swings than usual.

Conclusion

Injective’s deflationary token model and growing real-world asset trading provide solid support for the token. However, regulatory challenges and overall market conditions require careful attention. The SEC’s decision on Canary’s ETF, expected by October 15, will be a key event—approval could boost INJ’s status as an institutional asset, while rejection might test support around $12. Also, keep an eye on how Pineapple Financial’s treasury strategy affects selling pressure from retail investors.

What are people saying about INJ?

The Injective community is divided between optimism for a price breakout and concerns about a possible drop. Here’s what’s trending:

1. Optimists target $35 if a key resistance level is broken 🚀
2. Pessimists warn of a potential drop to $8 📉
3. Growth in Total Value Locked (TVL) boosts confidence in the ecosystem 💪

Deep Dive

1. @WorldOfCharts1: $35 Target If Resistance Breaks (Bullish)

“Once this horizontal area clears, Injective can hit $35”
– @WorldOfCharts1 (198K followers · 42K impressions · 2025-09-09 08:19 UTC)
View original post
What this means: If Injective’s price rises above $15.50, it could trigger buying momentum that pushes the price toward $25 to $35. However, the coin currently faces strong resistance around $13 to $14, which it needs to overcome first.

2. @ali_charts: Breakdown to $8 Likely (Bearish)

“INJ has entered a new leg down!”
– @ali_charts (327K followers · 89K impressions · 2025-08-30 20:01 UTC)
View original post
What this means: If Injective’s price falls below the $12.50 support level, it could confirm a downward trend, with possible targets near $11.66 and $8.22. This pattern suggests a bearish outlook.

3. @kylobtc: TVL Growth Signals Strength (Bullish)

“TVL passes $50M – proof Injective is gaining traction”
– @kylobtc (86K followers · 28K impressions · 2025-09-22 08:33 UTC)
View original post
What this means: Total Value Locked (TVL) measures the amount of assets held in the Injective ecosystem. A rise above $50 million shows growing user activity and confidence. This growth also supports deflationary effects, as 6.6 million INJ tokens have been burned so far this year, reducing supply.

Conclusion

Opinions on Injective are mixed. On one hand, the ecosystem is growing with a 50% increase in TVL and integration with Ethereum Virtual Machine (EVM), which is positive. On the other hand, technical analysis warns of possible price drops. Long-term support comes from staking rewards and interest from institutional investors, including $1 million fund filings for ETFs. Traders should closely watch the $12.50 to $15.50 price range for signs of a breakout or breakdown. Also, monitoring weekly exchange netflows—how much INJ is moving in or out of exchanges—can provide clues, as steady accumulation might signal a shift toward bullish momentum.

What is the latest news about INJ?

Injective is making big moves to connect traditional finance with decentralized finance by launching pre-IPO derivatives and backing a $100 million treasury fund, even as regulatory concerns remain. Here’s the latest update:

1. Pre-IPO Perpetuals Launch (October 1, 2025) – Injective introduced onchain leveraged trading for private companies like OpenAI, offering a new alternative to platforms like Robinhood.
2. $100 Million Treasury Firm Heading to NYSE (September 11, 2025) – Pineapple Financial plans to buy and stake INJ tokens, supported by major institutional investors.
3. SEC Delays Approval of Staked INJ ETF (September 26, 2025) – Regulatory review slows down institutional access to Injective through ETFs.

Deep Dive

1. Pre-IPO Perpetuals Launch (October 1, 2025)

What happened:
Injective launched decentralized perpetual futures markets for private companies such as OpenAI and SpaceX through its Helix exchange. These contracts allow traders to use 5x leverage based on real-time price data from trusted sources, and trading is available 24/7. Unlike Robinhood’s tokenized equity products, which are limited to Europe, Injective’s platform is permissionless (except for users in the US, UK, and Canada) and can easily integrate with other decentralized finance (DeFi) applications.

Why it matters:
This move expands Injective’s role in bringing traditional private assets into the crypto world, giving traders new ways to invest in high-growth companies before they go public. However, the regulatory environment around synthetic equity derivatives is still unclear, which could pose challenges if authorities decide to intervene. (The Block)

2. $100 Million Treasury Firm Heading to NYSE (September 11, 2025)

What happened:
The Injective Foundation led a $100 million private investment into Pineapple Financial, a mortgage lender shifting toward managing digital assets. Pineapple plans to use this capital to buy and stake INJ tokens, aiming for a 12% annual return while holding about 7% of the total INJ supply. Executives from Injective will also join Pineapple’s advisory board.

Why it matters:
This partnership creates a strong demand for INJ tokens, which can reduce the circulating supply and potentially support the token’s price. It also connects Injective to traditional financial markets through Pineapple’s public market plans. Similar to how MicroStrategy invested heavily in Bitcoin, this strategy could help stabilize INJ’s value, but success depends on Pineapple’s ability to navigate the volatile crypto market. (CCN)

3. SEC Delays Approval of Staked INJ ETF (September 26, 2025)

What happened:
The U.S. Securities and Exchange Commission (SEC) postponed decisions on ETFs that would allow investors to gain exposure to staked INJ and SEI tokens. This delay is part of a broader cautious approach toward crypto staking products, following earlier delays for Avalanche ETFs, even though Bitcoin and Ethereum ETFs have been approved.

Why it matters:
These regulatory delays slow down the ability of institutional investors to access Injective through traditional investment vehicles like ETFs. However, the fact that these filings exist shows growing interest from traditional finance in crypto assets. Investors should watch for updates from SEC officials and political developments, especially with the 2026 midterm elections approaching. (The Block)

Conclusion

Injective is actively working to bridge decentralized finance and traditional markets through innovative derivatives and treasury investments. While the launch of pre-IPO perpetuals could boost trading volume and token demand, regulatory hurdles like ETF delays highlight ongoing challenges in crypto’s path to mainstream adoption.

The big question remains: Will decentralized synthetic assets grow faster than regulators can control them?

What is expected in the development of INJ?

Injective’s roadmap highlights three key areas: AI-driven app creation, cross-chain compatibility, and stronger tokenomics:

1. iBuild Launch (Q4 2025) – Build decentralized finance apps using simple text commands powered by AI.
2. MultiVM Mainnet (Q4 2025) – Support for Ethereum, Solana, and CosmWasm apps on one platform without rewriting code.
3. Monthly Community Burns (Ongoing) – Regular token burns to reduce supply and increase value of $INJ.

Deep Dive

1. iBuild Launch (Q4 2025)

Overview:
Introduced at the 2025 Injective Summit, iBuild lets users create Web3 finance apps just by typing instructions—no coding needed. A live demo showed a working app built in minutes.

What this means:
This is positive for INJ because it could attract many new developers and increase the variety of apps on Injective, boosting demand for $INJ as the platform’s utility token. However, AI-generated code might have some technical challenges to overcome.

2. MultiVM Mainnet (Q4 2025)

Overview:
MultiVM allows developers to run apps built for Ethereum (EVM), Solana (SVM), and CosmWasm directly on Injective without changing the code. The testnet is already live, with full launch expected by late 2025.

What this means:
This is a promising development that could make Injective a hub connecting multiple blockchains. Success depends on attracting developers from Ethereum and Solana ecosystems. The recent Ethernia upgrade improved Ethereum compatibility (MDCryptoWorld), making it easier to use Solidity-based apps.

3. Monthly Community Burns (Ongoing)

Overview:
After the Summit, Injective moved to monthly token burn auctions using smart contracts, pooling fees from all apps on the platform. So far, over 6.6 million INJ tokens (worth about $31 million) have been burned.

What this means:
This approach is designed to increase $INJ’s scarcity, which can help raise its value. However, the success of this depends on continued use of apps on Injective, which faces competition from other blockchains like Solana and Sei.

Conclusion

Injective is focusing on making blockchain development easier with AI (iBuild), connecting multiple blockchains (MultiVM), and strengthening its token value through regular burns. Backed by partners like Google Cloud and Deutsche Telekom, Injective aims to bridge traditional finance and crypto. The big question is whether it can keep up with other layer-1 blockchains rolling out similar features.

What updates are there in the INJ code base?

Injective recently updated its software to support Ethereum compatibility, improve performance, and boost security.

1. EVM Mainnet Launch (August 31, 2025) – Allows Ethereum-based apps to run on Injective while accessing liquidity from the Cosmos network.
2. MultiVM Testnet Release (July 11, 2025) – Supports both Ethereum and Solana development tools for easier cross-chain projects.
3. v1.16.4 Performance Upgrade (September 25, 2025) – Speeds up network operations and improves efficiency for better reliability.

Deep Dive

1. EVM Mainnet Launch (August 31, 2025)

Overview: The Ethernia upgrade combines Ethereum Virtual Machine (EVM) compatibility with Injective’s existing system, letting developers use Ethereum’s popular programming language (Solidity) to build apps that also tap into liquidity from the Cosmos blockchain network.

Technically, this means Injective runs two environments side-by-side and connects with MetaMask (a popular Ethereum wallet) through a custom interface. Transactions are fast and cheap, costing less than a penny and confirming in about 0.64 seconds.

Why it matters: This is positive for INJ because it connects Ethereum’s large developer community with Injective’s fast and scalable platform, which could bring more decentralized finance (DeFi) projects to Injective. (Source)

2. MultiVM Testnet Release (July 11, 2025)

Overview: MultiVM lets developers build apps using either Ethereum’s or Solana’s virtual machines without changing their code. This upgrade introduced a new system that splits processing tasks (called sharding), lowering transaction fees by about 40% for complex smart contracts. Alongside this, a public test network launched with iBuild, an AI-powered tool that helps create apps without coding.

Why it matters: This is somewhat positive because it makes Injective more attractive to developers from different blockchain communities, though success depends on how many adopt it. Easier app deployment could speed up growth in Injective’s ecosystem. (Source)

3. v1.16.4 Performance Upgrade (September 25, 2025)

Overview: This required update for network validators improved how quickly blocks are shared across the network by 22% and reduced memory needed to sync data.

Key improvements include:

• More efficient execution of smart contracts using WASM technology
• Integration of PebbleDB for faster database operations
• Adjustments to consensus timing to avoid delays in block confirmation

Why it matters: This is positive for the long term because it makes the network more reliable and scalable, which is important for professional DeFi applications. Validators must update their software before the network pauses on September 25. (Source)

Conclusion

Injective’s latest updates focus on making the platform more interoperable (with Ethereum), flexible (supporting multiple virtual machines), and ready for enterprise use (through performance improvements). These changes support Injective’s goal to be a key infrastructure layer for DeFi. With institutional players like NTT Digital joining as validators, it will be interesting to see how these technical advances influence INJ’s role in tokenizing real-world assets.